Adjuvant therapy of resectable rectal cancer
- 1 August 2002
- journal article
- review article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 28 (4) , 181-188
- https://doi.org/10.1016/s0305-7372(02)00037-3
Abstract
No abstract availableKeywords
This publication has 67 references indexed in Scilit:
- ZD1839, a Selective Oral Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitor, Is Well Tolerated and Active in Patients With Solid, Malignant Tumors: Results of a Phase I TrialJournal of Clinical Oncology, 2002
- Postoperative pelvic radiotherapy with or without elective irradiation of para-aortic nodes and liver in rectal cancer patients. A controlled clinical trial of the EORTC Radiotherapy GroupRadiotherapy and Oncology, 2001
- Addition of Oxaliplatin to Continuous Fluorouracil, l-Folinic Acid, and Concomitant Radiotherapy in Rectal Cancer: The Lyon R 97-03 Phase I TrialJournal of Clinical Oncology, 2001
- Adjuvant versus Neoadjuvant Radiochemotherapy for Locally Advanced Rectal Cancer A Progress Report of a Phase-III Randomized Trial (Protocol CAO/ARO/AIO-94)Strahlentherapie und Onkologie, 2001
- Randomized Trial of Postoperative Adjuvant Chemotherapy With or Without Radiotherapy for Carcinoma of the Rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02JNCI Journal of the National Cancer Institute, 2000
- T3N0 rectal cancer: results following sharp mesorectal excision and no adjuvant therapyJournal of Gastrointestinal Surgery, 1999
- Prognostic factors in Stage T2NO rectal cancerDiseases of the Colon & Rectum, 1999
- Combined modality therapy of rectal cancer: decreased acute toxicity with the preoperative approach.Journal of Clinical Oncology, 1992
- Effective Surgical Adjuvant Therapy for High-Risk Rectal CarcinomaNew England Journal of Medicine, 1991
- Adjuvant Therapy for Patients With Colon and Rectal CancerJAMA, 1990